[PDF][PDF] Cetuximab: from bench to bedside
Current cancer drug targets, 2010 - researchgate.net
Cetuximab (IMC-C225, Erbitux ImClone Systems Inc, New York, NY) is a recombinant,
human/mouse chimeric monoclonal antibody (MAb) that binds specifically to the …
human/mouse chimeric monoclonal antibody (MAb) that binds specifically to the …
[引用][C] CETUXIMAB: From Bench to Bedside
B Vincenzi, A Zoccoli, F Pantano… - Current Cancer Drug …, 2010 - ingentaconnect.com
Cetuximab (IMC-C225, Erbitux ImClone Systems Inc, New York, NY) is a recombinant,
human/mouse chimeric monoclonal antibody (MAb) that binds specifically to the …
human/mouse chimeric monoclonal antibody (MAb) that binds specifically to the …
CETUXIMAB: From bench to bedside
B Vincenzi, A Zoccoli, F Pantano… - CURRENT CANCER …, 2010 - iris.unicampus.it
Abstract Cetuximab (IMC-C225, Erbitux ImClone Systems Inc, New York, NY) is a
recombinant, human/mouse chimeric monoclonal antibody (MAb) that binds specifically to …
recombinant, human/mouse chimeric monoclonal antibody (MAb) that binds specifically to …
Cetuximab: from bench to bedside.
B Vincenzi, A Zoccoli, F Pantano, O Venditti… - Current Cancer Drug …, 2010 - europepmc.org
Cetuximab (IMC-C225, Erbitux ImClone Systems Inc, New York, NY) is a recombinant,
human/mouse chimeric monoclonal antibody (MAb) that binds specifically to the …
human/mouse chimeric monoclonal antibody (MAb) that binds specifically to the …
Cetuximab: from bench to bedside
B Vincenzi, A Zoccoli, F Pantano… - … cancer drug targets, 2010 - pubmed.ncbi.nlm.nih.gov
Cetuximab (IMC-C225, Erbitux ImClone Systems Inc, New York, NY) is a recombinant,
human/mouse chimeric monoclonal antibody (MAb) that binds specifically to the …
human/mouse chimeric monoclonal antibody (MAb) that binds specifically to the …
[PDF][PDF] CETUXIMAB: From Bench to Bedside
B Vincenzi, A Zoccoli, F Pantano… - Current Cancer Drug …, 2010 - researchgate.net
Cetuximab (IMC-C225, Erbitux ImClone Systems Inc, New York, NY) is a recombinant,
human/mouse chimeric monoclonal antibody (MAb) that binds specifically to the …
human/mouse chimeric monoclonal antibody (MAb) that binds specifically to the …
[引用][C] CETUXIMAB: From Bench to Bedside
B Vincenzi, A Zoccoli, F Pantano, O Venditti… - Current Cancer Drug …, 2010 - cir.nii.ac.jp
CETUXIMAB: From Bench to Bedside | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
CETUXIMAB: From bench to bedside
B Vincenzi, A Zoccoli, F Pantano… - CURRENT CANCER …, 2010 - iris.unicampus.it
Abstract Cetuximab (IMC-C225, Erbitux ImClone Systems Inc, New York, NY) is a
recombinant, human/mouse chimeric monoclonal antibody (MAb) that binds specifically to …
recombinant, human/mouse chimeric monoclonal antibody (MAb) that binds specifically to …